Stephanie L. Martch
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (3)
Background: Alcohol, a known carcinogen since 1988, increases risk of cancers of the mouth, pharynx, larynx, esophagus, liver, breast, and colorectum. More than one half of US adults consume alcohol whereas about two thirds are unsure whether or unaware that alcohol intake is linked to cancer risk. Methods: Our objective was to survey awareness, beliefs, intentions, policies, practices, and goals/perceived responsibilities related to establishing/promoting actions to reduce alcohol-related cancer risks from leaders of 72 NCI-Designated Cancer Centers. Results: Sixty-one percent responded. Forty-three percent either believed in or were uncertain about alcohol’s purported health benefits. Nevertheless, 86% considered it part of their job to warn the public about alcohol’s carcinogenic effects. Fifty-two percent had at least one alcohol-related policy in place; among that subset, 83% had a policy related to alcohol service during on-site events; 87% had one about reimbursement of that alcohol service. Of concern, only 45% of survey respondents agreed that current literature with regard to alcohol-related cancer risk factors was sufficient to warrant a reconsideration of their alcohol-related policies/practices, and fewer than half have acted on those data. Conclusions: NCI-Designated Cancer Centers can implement policies and change practices now to reduce alcohol intake and the cancer deaths associated with its consumption. Impact: Cancer centers’ leadership in alcohol practices and policies may energize the public to be more thoughtful about their use of alcohol, resulting in long-term reductions in associated cancer risks. See related In the Spotlight, p. 190
Year:
2026
Background: Alcohol, a known carcinogen since 1988, increases risk of cancers of the mouth, pharynx, larynx, esophagus, liver, breast, and colorectum. More than one half of US adults consume alcohol whereas about two thirds are unsure whether or unaware that alcohol intake is linked to cancer risk. Methods: Our objective was to survey awareness, beliefs, intentions, policies, practices, and goals/perceived responsibilities related to establishing/promoting actions to reduce alcohol-related cancer risks from leaders of 72 NCI-Designated Cancer Centers. Results: Sixty-one percent responded. Forty-three percent either believed in or were uncertain about alcohol’s purported health benefits. Nevertheless, 86% considered it part of their job to warn the public about alcohol’s carcinogenic effects. Fifty-two percent had at least one alcohol-related policy in place; among that subset, 83% had a policy related to alcohol service during on-site events; 87% had one about reimbursement of that alcohol service. Of concern, only 45% of survey respondents agreed that current literature with regard to alcohol-related cancer risk factors was sufficient to warrant a reconsideration of their alcohol-related policies/practices, and fewer than half have acted on those data. Conclusions: NCI-Designated Cancer Centers can implement policies and change practices now to reduce alcohol intake and the cancer deaths associated with its consumption. Impact: Cancer centers’ leadership in alcohol practices and policies may energize the public to be more thoughtful about their use of alcohol, resulting in long-term reductions in associated cancer risks. See related In the Spotlight, p. 190
Year:
2025
The American College of Physicians (ACP) update of their standing guidance statement for colorectal-cancer screening in asymptomatic average-risk adults was recently published to assist clinicians with implementing evidence-based patient care. After assessing existing guideline literature, the ACP recommended five actions: consider not screening adults ages 45 to 49 years; stop screening adults older than 75 years; discuss benefits, harms, costs, availability, frequency, and patient values/preferences with patients prior to choosing a screening method; and when choosing, recommend biennial rather than annual use of a fecal immunochemical test or a guaiac fecal occult blood test and avoid recommending computed tomography colonography or stool DNA tests. While the ACP guidelines are rigorous, well-intended, and considerate of patients’ input, their greatest impact may result from highlighting the need for researchers to help frontline clinicians to describe the risk, costs, and benefits/harms of various colorectal-cancer screening strategies in an effective, yet time-efficient, manner given the all-too-brief annual patient encounters. In the United States, reimbursement is still dependent on U.S. Preventive Services Task Force recommendations which are somewhat more liberal in contrast to the ACP's approach which strongly favors randomized, controlled trial evidence to guide the delivery of prevention and screening services to asymptomatic average-risk patients.
Year:
2024
Collaborators (2)
Sanjay Shete
The University of Texas MD Anderson Cancer Center
Ernest Hawk
The University of Texas MD Anderson Cancer Center
Make your next move.
Prepare your application
Review drafts before you send them.